AMASS Brands Invests in THC Beverages with Afterdream Deal
AMASS Brands Group announced a SAFE investment in Afterdream, a hemp-derived THC beverage brand, securing a right to at least a 15.67% fully diluted ownership stake.
Key Numbers
AMASS Brands Group (NASDAQ:AMSS), a beverage platform, announced Wednesday that it entered into a Simple Agreement for Future Equity (SAFE) investment in Afterdream, a hemp-derived THC beverage brand. The deal secures AMASS the right to receive at least a 15.67% fully diluted ownership stake.
Deal Details
- Investor: AMASS Brands Group
- Target: Afterdream
- Instrument: SAFE (Simple Agreement for Future Equity)
- Stake: 15.67% fully diluted
Rationale
AMASS aims to expand its portfolio in the functional beverage space, particularly THC-infused drinks. Afterdream produces non-alcoholic beverages with organic lion's mane mushrooms, aligning with AMASS's focus on natural ingredients.
Regulatory Challenges
THC beverage regulations remain fragmented across U.S. states. The deal may face hurdles related to marketing and distribution compliance.
Stock Impact
Investors may view this as a strategic entry into a high-growth market, but regulatory risks could temper enthusiasm. No immediate stock reaction was reported.
Frequently Asked Questions
Found this useful? Share it